The levels of exosomal fibronectin and developmental endothelial locus-1 (EDIL3) were significantly higher in breast cancer patients than controls and dramatically reduced after tumor resection, suggesting that they may serve as important diagnostic and prognostic markers for breast cancer patients [71, 72]. Here, FN1 is linked to breast cancer.